Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devenport

Showing results (81-90 of 197) with videos related to

Pageof 20
Sort By:
Cell and Tissue Research|February 24, 2005
Storage and secretion of Ag-Aper14, a novel peritrophic matrix protein, and Ag-Muc1 from the mosquito Anopheles gambiaeM Devenport, H Fujioka, M Donnelly-Doman, et al.
Physiology & Behavior|June 1, 1993
Exercise endurance in rats: roles of type I and II corticosteroid receptorsL Devenport, D Doughty, B Heiberger, et al.
Archives of Physical Medicine and Rehabilitation|May 1, 1984
Formaldehyde generation from methenamine salts in spinal cord injuryJ K Devenport, J R Swenson, G E Dukes, et al.
Behavioral Sciences (Basel, Switzerland)|November 27, 2025
Exploring Lay Understandings of Romantic Chemistry Using Inductive and Deductive Content AnalysisScott Devenport, Matthew J Phillips, Barbara Mullan, et al.
Development (Cambridge, England)|September 3, 2024
Mesenchymal Vangl1 and Vangl2 facilitate airway elongation and widening independently of the planar cell polarity complexSarah V Paramore, Katharine Goodwin, Eric W Fowler, et al.
Rheumatology (Oxford, England)|July 4, 2012
Improvements in health-related quality of life after treatment with tocilizumab in patients with rheumatoid arthritis refractory to tumour necrosis factor inhibitors: results from the 24-week randomized controlled RADIATE studyVibeke Strand, Gerd R Burmester, Sarika Ogale, et al.
The Journal of Rheumatology|January 17, 2014
Continued benefit of tocilizumab plus disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritis and inadequate clinical responses by week 8 of treatmentEdward C Keystone, Andrew Anisfeld, Sarika Ogale, et al.
Developmental Cell|April 3, 2024
Vangl-dependent mesenchymal thinning shapes the distal lung during murine sacculationSarah V Paramore, Carolina Trenado-Yuste, Rishabh Sharan, et al.
BMJ (Clinical Research Ed.)|April 8, 1989
Determinants of bone density in normal women: risk factors for future osteoporosis?J C Stevenson, B Lees, M Devenport, et al.
Rheumatology International|June 1, 2015
Interpreting the multi-biomarker disease activity score in the context of tocilizumab treatment for patients with rheumatoid arthritisWilliam G Reiss, Jenny N Devenport, Jason M Low, et al.
Pageof 20

Showing results (81-90 of 197) with videos related to

Sort By:
Pageof 20
Cell and Tissue Research|February 24, 2005
Storage and secretion of Ag-Aper14, a novel peritrophic matrix protein, and Ag-Muc1 from the mosquito Anopheles gambiaeM Devenport, H Fujioka, M Donnelly-Doman, et al.
Physiology & Behavior|June 1, 1993
Exercise endurance in rats: roles of type I and II corticosteroid receptorsL Devenport, D Doughty, B Heiberger, et al.
Archives of Physical Medicine and Rehabilitation|May 1, 1984
Formaldehyde generation from methenamine salts in spinal cord injuryJ K Devenport, J R Swenson, G E Dukes, et al.
Behavioral Sciences (Basel, Switzerland)|November 27, 2025
Exploring Lay Understandings of Romantic Chemistry Using Inductive and Deductive Content AnalysisScott Devenport, Matthew J Phillips, Barbara Mullan, et al.
Development (Cambridge, England)|September 3, 2024
Mesenchymal Vangl1 and Vangl2 facilitate airway elongation and widening independently of the planar cell polarity complexSarah V Paramore, Katharine Goodwin, Eric W Fowler, et al.
Rheumatology (Oxford, England)|July 4, 2012
Improvements in health-related quality of life after treatment with tocilizumab in patients with rheumatoid arthritis refractory to tumour necrosis factor inhibitors: results from the 24-week randomized controlled RADIATE studyVibeke Strand, Gerd R Burmester, Sarika Ogale, et al.
The Journal of Rheumatology|January 17, 2014
Continued benefit of tocilizumab plus disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritis and inadequate clinical responses by week 8 of treatmentEdward C Keystone, Andrew Anisfeld, Sarika Ogale, et al.
Developmental Cell|April 3, 2024
Vangl-dependent mesenchymal thinning shapes the distal lung during murine sacculationSarah V Paramore, Carolina Trenado-Yuste, Rishabh Sharan, et al.
BMJ (Clinical Research Ed.)|April 8, 1989
Determinants of bone density in normal women: risk factors for future osteoporosis?J C Stevenson, B Lees, M Devenport, et al.
Rheumatology International|June 1, 2015
Interpreting the multi-biomarker disease activity score in the context of tocilizumab treatment for patients with rheumatoid arthritisWilliam G Reiss, Jenny N Devenport, Jason M Low, et al.
Pageof 20